• Home
  • About
    • CV
    • Testimonials
  • Videos
    • About Dr. Sharlin
    • Dr. Sharlin in the News
  • $495M Verdict
  • My 40 Classes
  • Articles
  • Contact
  • Home
  • About
    • CV
    • Testimonials
  • Videos
    • About Dr. Sharlin
    • Dr. Sharlin in the News
  • $495M Verdict
  • My 40 Classes
  • Articles
  • Contact

FDA’s Requirements for Financial Disclosure

by Dr. Joshua Sharlin, Ph.D. | Jan 8, 2019 | FDA Regulatory, FDA’s Requirements for Financial Disclosure

Download this content as a slide deck A detailed description of FDA requirements for financial disclosure by clinical investigators. The content includes; 1) Five key definitions, 2) Five significant penalties for noncompliance, 3) Dollar thresholds that trigger...

Recent Posts

  • Solensia: Pet owner warns others to new arthritis drug
  • FDA launched safety review into broken IUDs after Spotlight inquiry
  • Video on Cases
  • Video on Teaching
  • Video on Methodology

Recent Comments

    Archives

    • April 2025
    • March 2025
    • January 2025
    • December 2020
    • January 2019

    Categories

    • FDA and DEA Litigation Briefing
    • FDA Expert Witness
    • FDA Regulatory
    • FDA’s Requirements for Financial Disclosure
    • In The News
    • Videos
    • What Needs to be in an FDA Product Submission: A Reviewer’s Perspective

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Designed by Elegant Themes | Powered by WordPress